Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-010920
Filing Date
2019-04-05
Accepted
2019-04-05 16:10:30
Documents
8
Period of Report
2019-05-22
Effectiveness Date
2019-04-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A alks-def14a_20190522.htm DEF 14A 3322936
2 GRAPHIC gaild53xht2p000006.jpg GRAPHIC 153722
3 GRAPHIC gaild53xht2p000003.jpg GRAPHIC 4902
4 GRAPHIC gaild53xht2p000002.jpg GRAPHIC 3156
5 GRAPHIC gaild53xht2p000004.jpg GRAPHIC 17152
6 GRAPHIC gaild53xht2p000005.jpg GRAPHIC 23112
7 GRAPHIC gaild53xht2p000001.jpg GRAPHIC 4902
8 GRAPHIC gaild53xht2p000007.jpg GRAPHIC 116501
  Complete submission text file 0001564590-19-010920.txt   3770696
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35299 | Film No.: 19735243
SIC: 2834 Pharmaceutical Preparations